Intoolab secures seed funding from Startup Funding Club for its artificial intelligence scientist.
Startup Funding Club backs artificial intelligence biomedicine startup Intoolab in its seed round.
Intoolab has built Tzager, an artificial intelligence platform designed to assist researchers and medical professionals in the biomedicine sector.
Startup Funding Club has completed a seed investment in Intoolab to support the development of its artificial intelligence scientist, Tzager. The funding comes from Startup Funding Club funds and the SFC Angel Network. Intoolab will use the capital to advance its AI technology and establish a presence across the UK and European biomedicine markets. The company has spent several years refining its platform in collaboration with academic research teams.
From the founder
"We are thrilled to be part of such an important portfolio and to work closely with such a great team like SFC. Since the first time we met, Stephen Page showed us that we understand each other and share the same ambition towards global reach and technological excellence. Our main goal is to show the Medicine world that Intoolab and Tzager will soon be the closest they can get to true AI – especially when talking about drug discovery. You cannot have better scientists than those that can process millions of data in minutes, while at the same time understanding the whole process from a research objective to its completion. This is what we do."
Nikos Tzagkarakis
CEO at Intoolab
Investor perspective
"It was obvious when we first met the Intoolab team that they had something very special. Their Tzager product will bring the world’s medical knowledge into the grasp of students and researchers everywhere. The “wikipedia” of medical knowledge – and we are delighted to be part of Intoolab’s journey."
Stephen Page
CEO, Startup Funding Club
Use of funds
- 01Continue product development
- 02Expand into international markets
.png)